Reply to: Minocycline versus tetracycline in bismuth-containing quadruple therapy for Helicobacter pylori rescue treatment: a multicentre, randomized controlled trial

被引：0
|
作者：
Huang, Yu [1 ]
Lu, Hong [1 ]
机构：
[1] Shanghai Jiao Tong Univ, Div Gastroenterol & Hepatol, NHC Key Lab Digest Dis, Shanghai Inst Digest Dis,Sch Med,Renji Hosp, Shanghai, Peoples R China
来源：
JOURNAL OF GASTROENTEROLOGY | 2024年 / 59卷 / 04期
关键词：
ERADICATION;
D O I：
10.1007/s00535-024-02085-z
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：358 / 358
页数：1
相关论文
共 50 条
  • [31] Second-line bismuth-containing quadruple therapy for Helicobacter pylori eradication and impact of diabetes
    Kim, Sung Eun
    Park, Moo In
    Park, Seun Ja
    Moon, Won
    Kim, Jae Hyun
    Jung, Kyoungwon
    Kim, Hae Koo
    Dal Lee, Young
    WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (06) : 1059 - 1066
  • [32] Moxifloxacin-Containing Triple Therapy versus Bismuth-Containing Quadruple Therapy for Second-Line Treatment of Helicobacter pylori Infection: A Meta-Analysis
    Wu, Cheng
    Chen, Xiao
    Liu, Jing
    Li, Ming-Yang
    Zhang, Zi-Qi
    Wang, Zhi-Qiang
    HELICOBACTER, 2011, 16 (02) : 131 - 138
  • [33] META-ANALYSIS OF LEVOFLOXACIN-CONTAINING TRIPLE THERAPY VERSUS BISMUTH-CONTAINING QUADRUPLE THERAPY AS SECOND-LINE TREATMENT IN THE ERADICATION OF HELICOBACTER PYLORI
    Marin, A. C.
    McNicholl, A. G.
    Gisbert, J. P.
    HELICOBACTER, 2011, 16 : 132 - 132
  • [34] Randomized, double-blind, placebo-controlled clinical trial on the usefulness of probiotic Lactobacillus reuteri in bismuth-containing quadruple eradication therapy for infection with Helicobacter pylori
    Moreno Marquez, Carolina
    Fernandez Alvarez, Paula
    Valdes Delgado, Teresa
    Castro Laria, Luisa
    Arguelles Arias, Federico
    Caunedo Alvarez, Angel
    Gomez Rodriguez, Blas Jose
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2022, 114 (02) : 89 - 95
  • [35] Comparison of Bismuth Containing Quadruple Therapy and Tailored Therapy for Helicobacter pylori Eradication According to Clarithromycin Resistance: A Prospective Randomized Controlled Trial
    Bang, Byoung Wook
    Ko, Eun Jung
    Kwon, Kye Sook
    Shin, Yong Woon
    Kim, Hyung Kil
    DIGESTION, 2020, 101 (01) : 97 - 97
  • [36] Comparison of Bismuth containing quadruple therapy and tailored therapy for Helicobacter pylori eradication according to clarithromycin resistance; a prospective randomized controlled trial
    Kim, H.
    Bang, B.
    Ko, E.
    Shin, Y.
    HELICOBACTER, 2018, 23
  • [37] Therapeutic success with bismuth-containing sequential and quadruple regimens in Helicobacter pylori eradication
    Ozturk, Oguzhan
    Doganay, Levent
    Colak, Yasar
    Enc, Feruze Yilmaz
    Ulasoglu, Celal
    Ozdil, Kamil
    Tuncer, Ilyas
    ARAB JOURNAL OF GASTROENTEROLOGY, 2017, 18 (02) : 62 - 67
  • [38] High-Dose Dual Therapy Versus Bismuth-Containing Quadruple Therapy for the Treatment of Helicobacter pylori Infection: A Systematic Review with Meta-Analysis
    Yin, Zhikun
    Li, Ji
    Huang, Weifeng
    Lei, Xiaoyi
    Xu, Dong
    Xu, Guihua
    Li, Hua
    Zhang, Jinyan
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2022, 33 (06): : 454 - 462
  • [39] High-dose dual therapy versus bismuth-containing quadruple therapy for the treatment of Helicobacter pylori infection - A review of the strengths, weaknesses, and proposed solutions
    Hu, Chi-Tan
    TZU CHI MEDICAL JOURNAL, 2022, 34 (03): : 303 - 309
  • [40] Comparison of high-dose dual therapy with bismuth-containing quadruple therapy in Helicobacter pylori-infected treatment-naive patients: An open-label, multicenter, randomized controlled trial
    Guan, Jia-Lun
    Hu, Yun-Lian
    An, Ping
    He, Qiong
    Long, Hui
    Zhou, Lin
    Chen, Zhi-Fen
    Xiong, Jian-Guang
    Wu, Shi-Sheng
    Ding, Xiang-Wu
    Luo, He-Sheng
    Li, Pei-Yuan
    PHARMACOTHERAPY, 2022, 42 (03): : 224 - 232
12345